Prescription Drug Pricing and Its Implications

This chapter explores the Department of Health and Human Services' initiative to set new price targets for prescription drugs in alignment with other wealthy nations. It illustrates the financial burden on individuals through a couple's real-life experience and discusses the potential impacts of Trump’s favored nation policy. The conversation highlights the need for balance in drug pricing, addressing the complexities of pharmacy benefit managers and the implications of international pricing strategies.